Neurostimulator Market Share and Forecast to 2027

1
Neurostimulator Market Supply, Revenue and
Forecast from 2020 To 2026
www.reportsanddata.com
sales_at_reportsanddata.com
2
Market Summary
Increasing prevalence of chronic diseases, rising
geriatric population, growing number of unmet
medical needs, increasing evidences of
neurological diseases, rising demand for
minimally invasive surgeries are key factors
contributing to high CAGR of Neurostimulator
during forecast period. Market Size USD 4.98
Billion in 2018, Market Growth - CAGR of 12.4,
Market Trends Product launches and research for
advanced Neurostimulator
3
Our Approach
Market Summary

• According to the current analysis of Reports and
  Data, the global Neurostimulator market was
  valued at USD 4.98 Billion in 2018 and is
  expected to reach USD 12.7 Billion by the year
  2026, at a CAGR of 12.4 . Neurostimulator -
  Neurostimulator or Neurostimulation are equipment
  that is used for neuromodulation. The process of
  making use of an implantable medical device to
  alter and modulate neural activities for
  therapeutic purposes is called neuromodulation.
  The recent emergence of Neurostimulator as a
  neural activity modulator is a major disruptive
  finding in the healthcare sector. In line with
  this, market leaders, as well as emerging
  players, are developing mechanisms that can be
  used for neural activities modulation. For
  instance, Medtronic plc US-based medical device
  company launched EnterraII gastric
  neurostimulator, a programmable device that
  generates mild electrical pulses for gastric
  electrical stimulation to treat chronic,
  intractable nausea and vomiting due to
  gastroparesis.
• Rising prevalence of chronic diseases and
  lifestyle health disorders, unmet needs of
  patients are pushing the technological
  development, significant focus of healthcare
  companies on development of novel mechanisms,
  upcoming patent expiry, availability of private
  as well public funds for research, and
  affirmative regulatory scenario all over the
  globe, are some of the notable factors boosting
  market growth in the industry.
• Key participants in Neurostimulator include
  Medtronic PLC, BioControl Medical, St. Jude
  Medical, Spinal Modulation, Boston Scientific
  Corp., Synapse Biomedical Inc., Cochlear,
  Cyberonics, Inc., and Nevro Corp.
• To Get Sample Copy of Report visit
  https//www.reportsanddata.com/sample-enquiry-form
  /2303

4
Our Approach
Market Summary

• Segments covered in the report
• Product Type (Revenue, USD Million 20162026)
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Gastric Electric Stimulators
• Application Type (Revenue, USD Million
  20162026)
• Pain Management
• Epilepsy
• Essential Tremor
• Urinary and Fecal Incontinence
• Depression
• Dystonia
• Gastroparesis
• Parkinson's Disease
• Others

5
Our Approach
Market Summary

• Type (Revenue, USD Million 20162026)
• Implantable
• External
• End Use (Revenue, USD Million 20162026)
• Hospitals/Clinics
• Cognitive Care Centers
• Research Institutes
• Others
• Do you have questions about the Report or want to
  inquire about a Discount? Ask our Expert
  https//www.reportsanddata.com/discount-enquiry-fo
  rm/2303

6
Our Approach
Market Summary

• Further key findings from the report suggest
• Neurostimulator market is growing at a CAGR of
  13.6 in the Asia Pacific, followed by North
  America and Europe, with 12.3 and 12.1 CAGR,
  respectively. Rising chronic disease prevalence
  across the globe is the prominent factor to
  accelerate the Neurostimulator market growth
  during forecast period across all regions
• As of 2018, Spinal Cord Stimulators is the
  dominating Neurostimulator, which holds 35.5 of
  the global market. European regional market is
  the chief revenue-generating source for this
  product segment, followed by North America,
  Asia-Pacific, and other regions
• Sacral Nerve Stimulators is expected to be the
  fastest-growing market segment during the
  forecast period 2019-2026, with a CAGR of 13.2.
  However, associated stringent government
  regulation is a major challenge for the
  Neurostimulator market growth of this market
  segment
• Pain Management application type segment was
  valued at USD 2.03 billion in 2018 and is
  expected to reach USD 5.3 billion by 2026
• The Asia Pacific is expected to account for 19.4
  of the global Neurostimulator market. Developing
  nations such as China and India are likely to
  observe high growth
• Read More _at_ https//www.reportsanddata.com/report-
  detail/neurostimulation-devices-market

7
Our Approach
About Us

• Reports and Data is a market research and
  consulting company that provides syndicated
  research reports, customized research reports,
  and consulting services. Our solutions purely
  focus on your purpose to locate, target and
  analyze consumer behavior shifts across
  demographics, across industries and help clients
  make a smarter business decision. We offer market
  intelligence studies ensuring relevant and
  fact-based research across a multiple industries
  including Healthcare, Technology, Chemicals,
  Power, and Energy. We consistently update our
  research offerings to ensure our clients are
  aware about the latest trends existent in the
  market. Reports and Data has a strong base of
  experienced analysts from varied areas of
  expertise.
• Contact Us
• John Watson
• Head of Business Development
• Reports And Data Web www.reportsanddata.com
• Direct Line 1-212-710-1370
• E-mail sales_at_reportsanddata.com